ClinConnect ClinConnect Logo

Main Menu

Search for Trials
Browse by Condition
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up

Clinical Trials for Acute Lymphoblastic Leukemia

Find clinical trials for acute lymphoblastic leukemia. Discover research opportunities and treatment options in your area.

142 Active Trials Found

Showing 142 trials on this page

Page 5 of 8

Using Text Messages to Improve Oral Chemotherapy for Adolescents and Young Adults With Acute Lymphoblastic Leukemia

NCT ID: NCT06446661

This clinical trial is looking at whether sending text message reminders can help young people with Acute Lymphoblastic Leukemia (ALL) remember to take their chemotherapy medications regularly. The...

Not yet recruiting
Phase: NA Type: interventional Locations: Chicago, Illinois, United States

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

NCT ID: NCT04195633

This clinical trial is studying a new treatment approach for patients with various types of blood cancers, such as acute leukemia and lymphoma. The treatment combines a donor stem cell transplant w...

Recruiting
Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1

NCT ID: NCT06777264

This clinical trial is exploring a new treatment called Inaticabtagene Autoleucel (or Inati-cel) for patients who have just been diagnosed with a type of blood cancer known as B-cell Acute Lymphobl...

Not yet recruiting
Phase: PHASE2 Type: interventional

Interfant-21 Treatment Protocol for Infants Under 1 Year with KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia

NCT ID: NCT05327894

The Interfant-21 clinical trial is studying a treatment for infants under 1 year old who have been diagnosed with a type of blood cancer called acute lymphoblastic leukemia (ALL), specifically thos...

Recruiting
Phase: PHASE3 Type: interventional Locations: Tampere, , Finland, Perth, Western Australia, Australia +77 more

90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome

NCT ID: NCT05139004

This clinical trial is exploring a new treatment approach for patients with high-risk acute leukemia or myelodysplastic syndrome, which are serious blood disorders. The study is testing a combinati...

Recruiting
Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.

NCT ID: NCT06752785

This clinical trial is investigating a new treatment called CD19/CD22 CAR-T cell therapy for children with a type of cancer known as B-lineage acute lymphoblastic leukemia (ALL) who still have dete...

Recruiting
Phase: PHASE1 Type: interventional Locations: Guangzhou, Guangdong, China

Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis

NCT ID: NCT06756152

This clinical trial is exploring a new way to prevent a serious condition called graft-versus-host disease (GVHD) in children and young adults who have certain types of blood cancers, like leukemia...

Recruiting
Phase: PHASE2 Type: interventional Locations: Moscow, , Russian Federation

Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

NCT ID: NCT04606433

This clinical trial is studying a new treatment called GNC-038, which is a special type of antibody designed to help patients with certain blood cancers, specifically non-Hodgkin's lymphoma and acu...

Recruiting
Phase: PHASE1 Type: interventional Locations: Guangzhou, , China, Beijing, Beijing, China +10 more

Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

NCT ID: NCT03571321

This clinical trial is looking at whether adding a medication called ruxolitinib to standard chemotherapy is safe and effective for young people, specifically adolescents and young adults, who have...

Recruiting
Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States

CAV Regimen for R/R Ph- B-ALL

NCT ID: NCT05657652

This clinical trial is studying a new treatment called the CAV regimen for patients with a type of leukemia known as Philadelphia Chromosome-negative B-cell acute lymphoblastic leukemia (B-ALL) tha...

Recruiting
Phase: NA Type: interventional Locations: Suzhou, Jiangsu, China

Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML

NCT ID: NCT06452732

This clinical trial is studying a new way to predict relapse in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Researchers believe that certain cells called leuk...

Recruiting
Type: observational Locations: Beijing, Beijing, China, Beijing, Beijing, China

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

NCT ID: NCT04065399

This clinical trial is studying a new medication called revumenib for patients with various types of acute leukemia, including those with specific genetic changes. The trial has two phases: the fir...

Recruiting
Phase: PHASE1 Type: interventional Locations: Columbus, Ohio, United States, Philadelphia, Pennsylvania, United States +62 more

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults with Relapsed/Refractory AML, ALL, or MPAL

NCT ID: NCT04872478

This clinical trial is studying a new medication called MRX-2843, which is being tested in adolescents and adults who have certain types of leukemia—specifically, those whose disease has come back ...

Recruiting
Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Atlanta, Georgia, United States +1 more

Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

NCT ID: NCT03422731

This clinical trial is looking at how total body irradiation (TBI) and chemotherapy affect the bone marrow in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Rese...

Recruiting
Phase: EARLY_PHASE1 Type: interventional Locations: Duarte, California, United States

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

NCT ID: NCT02508038

This clinical trial is looking at a new way to treat children with certain types of blood cancers (like leukemia and lymphoma) and high-risk solid tumors (like neuroblastoma and osteosarcoma). The ...

Recruiting
Phase: PHASE1 Type: interventional Locations: Madison, Wisconsin, United States

Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

NCT ID: NCT06195891

This clinical trial is studying a new treatment approach for patients with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or myelodysplastic syndrome (MDS). The trial combines a ...

Recruiting
Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

Systemic Inflammation Response Index and C-Reactive Protein to Albumin Ratio in Acute Lymphoblastic Leukemia

NCT ID: NCT06674850

This clinical trial is studying how certain biological markers can help predict the outcome for patients with Acute Lymphoblastic Leukemia (ALL), a type of blood cancer. Specifically, the researche...

Not yet recruiting
Type: observational

Safety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease.

NCT ID: NCT06659653

This clinical trial is looking at a new treatment called PRG-2302 for adults with a type of blood cancer known as B-cell acute lymphoblastic leukemia (B-ALL) that has come back after previous treat...

Recruiting
Phase: EARLY_PHASE1 Type: interventional Locations: Jinzhou, Hubei, China

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

NCT ID: NCT05735717

This clinical trial, titled "MT2021-08 T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies," is exploring a new treatment approach for patients with certain blood cancer...

Recruiting
Phase: PHASE2 Type: interventional Locations: Minneapolis, Minnesota, United States

Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

NCT ID: NCT06128070

This clinical trial is studying a combination of three medications—ruxolitinib, tacrolimus, and methotrexate—to see if they can help prevent a condition called graft versus host disease (GVHD) in c...

Recruiting
Phase: PHASE2 Type: interventional Locations: Duarte, California, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →
Search All Trials Browse All Conditions